2,3-Dimethyl-6-(4-methylpiperazin-1-yl)quinoxaline

Catalog No.: 
ACPSOW467
CAS No.: 
383148-06-9
Molecular Formula: 
C15H20N4
Molecular Weight: 
256.35
2,3-Dimethyl-6-(4-methylpiperazin-1-yl)quinoxaline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$98.00InquiryInquiry
1g90%$284.00InquiryInquiry
5g90%$1406.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,3-Dimethyl-6-(4-methylpiperazin-1-yl)quinoxaline
IUPAC Name2,3-dimethyl-6-(4-methylpiperazin-1-yl)quinoxaline
MDL No.MFCD03011822
Molecular FormulaC15H20N4
Molecular Weight256.35
SMILESCN1CCN(C2=CC=C3N=C(C)C(C)=NC3=C2)CC1
InChI KeyMWOMRYHUSQVCNX-UHFFFAOYSA-N
Synonym2,3-DIMETHYL-6-(4-METHYLPIPERAZINO)QUINOXALINE;2,3-dimethyl-6-(4-methylpiperazin-1-yl)quinoxaline;Quinoxaline, 2,3-dimethyl-6-(4-methyl-1-piperazinyl)-;2,3-Dimethyl-6-(4-methyl-1-piperazinyl)quinoxalin
CAS No.383148-06-9

Synthetic Route by SureRoute

1. ACPSOW467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPSOW467 route product structure diagram
    ACPSOW467383148-06-9
Inquiry

2. ACPSOW467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPSOW467 route product structure diagram
    ACPSOW467383148-06-9
Inquiry

3. ACPSOW467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPSOW467 route product structure diagram
    ACPSOW467383148-06-9
Inquiry

Comments (0)